Abstract. The intracellular events regulating endothelial cell proliferation and organization into formalized capillaries are not known. We report that the protein kinase C activator [I-phorbol 12,13-dibutyrate (PDBu) suppresses bovine capillary endothelial (BCE) cell proliferation (Ks0 = 6 + 4 nM) and DNA synthesis in response to human hepatoma-derived growth factor, an angiogenic endothelial mitogen. In contrast, PDBu has no effect on the proliferation of bovine aortic endothelial cells and is mitogenic for bovine aortic smooth muscle and BALB/c 3T3 cells. Several observations indicate that the inhibition of human hepatoma-derived growth factor-stimulated BCE cell growth by PDBu is mediated through protein kinase C. (a) Different phorbol compounds inhibit BCE cell growth according to their potencies as protein kinase C activators (12-O-tetradecanoylphorbol 13-acetate > PDBu >> 13-phorbol 12,13-diacetate >>> 13-phorbol; ¢t-phorbol 12,13-dibutyrate; ~t-phorbol 12,13-didecanoate). (b) PDBu binds to a single class of specific, saturable sites on the BCE cell with an apparent Kd of 8 nM, in agreement with reported affinities of PDBu for protein kinase C in other systems. (c) Specific binding of PDBu to BCE cells is displaced by sn-l,2-dioctanoylglycerol, a protein kinase C activator and an analog of the putative second messenger activating this kinase in vivo. The weak protein kinase C activator, sn-l,2-dibutyrylglycerol, does not affect PDBu binding.
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GIOGENESIS, the formation of new capillaries, is relatively infrequent in normal adult tissues, but dramatically increases in growing tumors and several other pathological conditions (reviewed in Folkman, 1982 ). Angiogenesis in vivo requires not only increased proliferation of capillary endothelial cells but also organization of these cells into nonproliferating, differentiated blood vessels (Folkman et al., 1982) . Endothelial cell proliferation is stimulated in vitro by two classes of heparin-binding growth factors that have been isolated from a variety of sources and are structurally related to fibroblast growth factor (Shing et al., 1984; Gospodarowicz et al., 1984; Amaore and Klagsbrun, 1984; Maciag et al., 1984; Sullivan and Klagsbrun, 1985; reviewed in Lobb et al., 1986 and Thomas et al., 1986) . Since many of these mitogens cause angiogenesis in the rat or rabbit cornea and the chick embryo (D~,more, 1982; Shing et al., 1985; Klagsburn et al., 1986) , it has been postulated that they are endogenous angiogenic factors. While capillary endothelial cell growth control is clearly a very important component of in vivo angiogenesis, the intracellular events that regulate endothelial cell response to angiogenic mitogens are not known.
In the present study, we have investigated the role of the phospholipid/calcium-dependent protein kinase (protein kinase C) in capillary endothelial cell growth. In many other cell types, protein kinase C is thought to be involved in mitogenesis. Several agents, including mitogens such as platelet-derived growth factor and bombesin, cause increased hydrolysis of phosphatidylinositol-4,5-bisphosphate in their target cells Berridge, 1984; Michell, 1982; . One of the putative second messengers released upon phosphatidylinositol-4,5-bisphosphate hydrolysis is sn-l,2-diacylglycerol, which activates protein kinase C by increasing its affinity for calcium (Nishizuka, 1984) . Certain phorbol diesters are potent activators of protein kinase C, binding at the same site as diacylglycerol (Castagna et al., 1982) , and, it has been suggested that most, if not all, of the biological effects of these compounds are due to protein kinase C activation (Nishizuka, 1984; Kikkawa et al., 1983) . One of these actions is the stimulation of cell division in such cell types as Swiss 3T3 cells (Rozengurt et al., 1984; Dicker and Rosengurt, 1980) , lymphocytes (Kaibuchi et al., 1985; Gelfand et al., 1985) , thyroid cells (Bachrach et al., 1985) , and chick heart mesen-chymal cells (Balk et al., 1984) . Often, phorbol diesters exert their stimulatory effect in synergy with suboptimal concentrations of serum or other mitogens.
We have found that 13-phorbol 12,13-dibutyrate (PDBu) ~ and other protein kinase C activators inhibit, rather than stimulate, the proliferation of bovine capillary endothelial (BCE) cells in response to angiogenic endothelial mitogens such as human hepatoma-derived growth factor (HDGF; Klagsbrun et al., 1986) . In addition, we present evidence that the PDBu receptor in BCE ceils shares several characteristics, including diacylglycerol specificity, with protein kinase C. These findings imply that this protein kinase may be involved in an intracellular regulatory mechanism to suppress the response of endothelial ceils to angiogenic mitogens. We suggest that such a mechanism might be invoked during endothelial cell differentiation into nonproliferating capillary tubes.
Materials and Methods

Materials
Tris base, Hepes, EGTA, EDTA, p-toluenesulfonylfluoride, aprotinin, BSA, and histone (type IIIS) were purchased from Sigma Chemical Co. (St. Louis, MO). Phorbol compounds were from Sigma Chemical Co. or from LC Services Corporation (Woburn, MA). The sodium salt of ATP was from P-L Biochemicals (Piscataway, NJ). [5,6,9,11,12,14, 15-3H] arachidonic acid, and [3H]toluene were from Dupont-New England Nuclear (Boston, MA). SDS and 2-mercaptoethanol were from Bio-Rad Laboratories (Richmond, CA). Thin-layer chromatography plates were from EM Reagents (Cincinnati, OH). Tissue culture reagents were from Gibco (Grand Island, NY). Highly purified human HDGF was prepared by Robert Sullivan and Dr. Michael Klagsbrun, Departments of Surgery and Biological Chemistry, The Children's Hospital and Harvard Medical School (Klagsbrun et al., 1986) . The specific activity of this factor was 5 U/rig, with 1 U eliciting half-maximal stimulation of 3T3 cell DNA synthesis as described by Klagsbrun and Shing (1985) . sn-l,2-Dioctanoylglycerol (DiCs) and phosphatidylserine (PS) were obtained from Avanti Polar Lipids, Inc. (Birmingham, AL). sn-l,2-Dibutyrylglycerol (DiC4) was synthesized enzymatically and purified as described by Ebeling et al. (1985) , using dibutyrylphosphatidylcholine from Avanti Polar Lipids, Inc., and phospholipase C (type XIII) from Sigma Chemical Co. The concentrations of diacylglycerol or phorbol diester in stock solutions were measured by an ester determination procedure using alkaline hydroxylamine and ferric perchlorate (Kates, 1972) . All other reagents were from Fisher Scientific Co. (Pittsburgh, PA).
Cell Culture
BCE cells were isolated from bovine adrenal glands and cultured as described by Folkman et al. (1979) , except that 5 ~tl/ml retinal extract (Gitlin and DAmore, 1983; D~nore et al., 1981) was substituted for the mouse sarcoma-conditioned medium. Bovine aortic endothelial cells and bovine aortic smooth muscle cells were isolated and grown as described previously (Folkman et al., 1979; Voyta et al., 1984) . BALB/c 3T3 cells were obtained from Dr. Michael Klagsbrun.
Cell Proliferation Assays
Cell proliferation assays were performed in gelatinized 24-well dishes (Nunc, Roskilde, Denmark) as previously described (Klagsbrun and Shing, 1985; Shing et ai., 1984) . Unless otherwise specified, the medium was DME with 10 % calf serum. PDBu or other phorbol compounds were added as solutions in dimethylsulfoxide (Me2SO). Me, SO was added to all test 1. Abbreviations used in this paper: BCE, bovine adrenal capillary endothelial; DiC4, sn-l,2-dibutyrylglycerol; DiCs, sn-l,2-dioctanoylglycerol; HDGF, human hepatoma-derived growth factor; M~SO, dimethylsulfoxide; PDBu, 13-phorbol 12,13-dibutyrate; PIP2, phospatidylinositol-4,5-bisphosphate; PS, phosphatidylserine. , 1986) . The results given are the means + SEM of quadruplicate wells.
solutions and controls so that the final concentration was identical in all wells (<1%). After incubation with test substances for the indicated times, cells were trypsinized and counted using a cell counter (Coulter Electronics, Hialeah, FL). All assays were performed in quadruplicate.
Reversibility of PDBu Treatment
Cells were plated (50,000 cells/well) on a gelatinized 6-weU dish (35-ram diameter wells) and were incubated overnight in DME-10 % calf serum. The following day, the medium was changed to DME-10 % calf serum containing either 0.001% MeaSO (three wells) or 20 nM PDBu, 0.001% M~SO (three wells). The cells were incubated for 72 h, then the medium was replaced with DME-10 % calf serum for 48 h. The ceils from each experimental condition were trypsinized, pooled, and counted. Complete detachment of both types of cells was confirmed by light microscopy. The total cell number was 5.5 x 105 for the control and 1.3 x 105 for the PDBu-treated cultures. Cells were plated on gelatinlzed 24-well dishes at 10,000 cells/well (12 wells per condition) and were incubated in BCE growth medium. The medium was changed after 24 h and every 48 h thereafter. At each time point (1, 3, 5, and 7 d after plating) the cell numbers in control and PDBu-treated wells were determined. To compare growth rates, the logarithms of cell numbers (determined in triplicate wells) were plotted versus time (in days).
DNA Synthesis Assays
For experiments measuring the incorporation of [3H]thymidine into acidprecipitable material, cells were plated in gelatinized 24-well dishes (16-mm wells) at 15,000 cells/well. For autoradiography, cells were plated at equivalent densities on gelatinized 35-mm dishes or tissue culture chamber/slides (LabTek; Miles, Laboratories, Elkhart, IN). Unless otherwise indicated, the medium was DME with 1% calf serum and 0.1% Me, SO. Cells were incubated with [3H-methyl]thymidine and other test substances as described in the figure legends. For determining acid-precipitable radioactivity, the medium was aspirated and the cells were washed with Dulbecco's PBS. The cells were then washed twice for 5 rain with cold acetic acid/methanol (1:3) and twice for 10 min with cold 10% TCA. The precipitates were then washed with water and dissolved in three successive 0.15-ml aliquots of 0.3 N NaOH. For each well, these aliquots were pooled and added to 4 ml scintillation fluid (ReadySolv MP; Beckman Instruments, Inc., Fullerton, CA) containing 20 gl glacial acetic acid. Samples were counted for tritium in a scintillation spectrometer (LS 3801; Beckman Instruments, Inc.) and data were corrected for quenching using the H-number calibration method with tritiated toluene as standard. For autoradiography, cells were washed with PBS and fixed successively in Karnovsky's fixative and 1% OsO4. Slides or dishes were washed in water and allowed to air dry. Fixed cell monolayers were coated with Kodak Nuclear Track Emulsion, type NTB. After at least 1 wk exposure, the emulsions were developed and fixed according to the manufacturer's instructions.
PDBu Binding to BCE Cells
Cells were plated in gelatinized 24-well plates (16-mm diameter wells) at 15,000 cells/well and were incubated for 3-4 d in DME-10% calf serum. Immediately before binding assays were conducted, the cells from two or three wells were trypsinized and the average cell number was determined.
The medium was aspirated from the remaining wells and the cells were washed with 1 ml PBS. 1] followed by autoradiography.) Me2SO and ethanol were added to all test solutions so that the final concentrations were 1 and 0.8%, respectively. The cells were incubated at 37°C for the indicated times, the medium was aspirated, and the cells washed three times with 1 ml cold 0.9% NaC1, 50 mM Tris-HCl, pH 7.4. The cells were solubilized in three successive aliquots of 0.15 rni 1% SDS. For each well, these aliquots were pooled and counted in 15 ml of ReadySolv MP scintillation fluid. Data were corrected for quenching as described above. Maximal binding of PDBu under these conditions occurred within 60 rain and remained stable for at least 180 rain.
Preparation of BCE Cytosol
All procedures were carried out at 4°C. Cells from two confluent 75-cm 2 flasks were detached by incubation with agitation in PBS with 0.5 mM EDTA for 20 rain, followed by gentle scraping with a cell scraper (Costar, Cambridge, MA). The cells (1.5 × 107 cells) were collected by centrifugation and were resuspended in 0.5 ml of extraction buffer (50 mM Tris-HC1, pH 7.5, 0.5 mM EGTA, 2 mM EDTA, 1 mM p-toluenesulfonylfluoride, 20 mM 2-mercaptoethanol, and 10 ~tg/ml aprotinin). The mixture was homogenized in a 1-ml Dounce micro tissue grinder (Reactiware; Pierce Chemical Co., Rockford, IL), using five strokes with the A pestle. The tissue grinder was washed with an additional 1 mi extraction buffer, and the combined homogenate was centrifuged at 1,000 g for 10 rain. The supernatant was set aside, and the pellet was resuspended in 1 ml extraction buffer and centrifuged in the same manner as above. The pooled 1,000-g supernatants (3-ml volume) were centrifuged at 100,000 g for 30 rain. The resulting cytosolic supernatant was desalted by two successive cycles of concentration (to ,',,50-100 lal) and dilution (to 2 ml with extraction buffer minus aprotinin) in a (10-kD tool wt cutoff) microconcentration apparatus (Centricon 10; Amicon, Danvers, MA). The concentration steps were performed by centrifugation at 3,000 g for 2-4 h. The final cytosolic protein solution was collected and the membrane washed with extraction buffer, yielding a final volume of 400 ~tl. The protein concentration was determined with the Bio-Rad protein assay (Bio-Rad Laboratories), with BSA as a standard.
Protein Kinase Assays
Cytosolic preparations from BCE cells were incubated at 35°C in a reaction mixture containing 50 mM Tris-HCl, pH 7.5, 10 mM MgCI2, 0.5 mg/mi histone (type IIIS; Sigma Chemical Co.), 50 ~tM [y-32p]ATE and other substances as indicated. PS and DiCs were sonicated in water before addition to reactions. Reactions were terminated by spotting aliquots onto phosphocellulose filter paper (P81; Whatman, Inc., Clifton, NJ) and immediately washing with 75 mM phosphoric acid. The spotting and filtration were done in a Minifold apparatus (Schleicher and Schuell, Inc., Keene, NH) under vacuum. The filter paper was then removed from the apparatus and washed in 75 mM phosphoric acid. Spots were cut out from the filter paper and counted for 32p in 4 ml ReadySolv EP scintillation fluid. When desired, the amount of [T-32p]ATP remaining in the reaction mixtures was determined by thin-layer chromatography as described previously (Doctrow and Lowenstein, 1985) .
Measurement of lnositol Phosphate Production by BCE Cells
BCE cells (200,000 cells/well) were plated in DME-10% calf serum in 35-mm gelatinized tissue culture wells. After cells were attached, the medium was replaced with 1.5 ml DME-10% calf serum containing 10-25 ~tCi/ml [2-3H(N)]-myo-inositol (3H-inositol). (In later experiments, the medium was 10% DME-90% inositol-free DME [GIBCO special order] with 10% calf serum.) After prelabeling for 48 h, the cells were incubated for 30 rain in PBS with 15 mM LiCI2 (Besterman et al., 1986) . The medium was then replaced with 1 rni PBS with or without HDGF (20 U). At this time, zero time samples were prepared by removing medium from some wells and adding 1 rnl extraction solution (chloroform/methanol/HCl; 1:2:0.05). For each condition, duplicate or triplicate wells were prepared. The experimental wells were incubated for 20 min, then quenched with extraction solution as described for the zero time samples. All dishes were extracted for 20 min at room temperature, then washed twice with I ml extraction solution. Phase separation was achieved by adding 800 Ixl chloroform and 800 ~tl 1.2 N HCI. The aqueous phase was removed and the organic phase washed twice as described previously (Doctrow and Lowenstein, 1985) . The washes were pooled with the aqueous phase and the solvent was removed in a Speed-Vac (Savant Instruments, Inc., Hicksville, NY) without heat. The water-soluble inositol phosphates were separated by ion exchange chromatography and the peaks corresponding to inositol monophosphate, inositol diphosphate, and inositol triphosphate were collected and counted as described previously (Berridge, 1983) . To assess incorporation of [3H]-inositol into phosphatidylinositol, phosphatidylinositol-4-phosphate, and phosphatidylinositol-4,5-bisphosphate (PIP2), the organic layers were dried down and subjected to thin-layer chromatography in system III (DOCtrow and Lowenstein, 1985) followed by autofluorography.
Results
PDBu inhibited the proliferation of BCE cells in a concentration-dependent manner (Fig. 1) . In the absence of PDBu, the cells grew very slowly in serum alone, in agreement with previous reports (Folkman et al., 1979) , while HDGF caused their growth rate to nearly triple. Even in the presence of HDGE however, PDBu potently inhibited BCE cell growth. The concentration of the phorbol ester required to inhibit the number of population doublings by 50% was 6 + 4 nM (four separate proliferation experiments). Cells were examined daily by phase-contrast microscopy and there was no indication that PDBu caused increased cell detachment. Allowing BCE cells to attach to culture dishes for 6 h in the presence of 200 nM PDBu did not affect cell plating efficiency. PDButreated cells and untreated cells stained equally well with the viability indicator fluorescein diacetate. In addition, PDBumediated growth inhibition was reversible. When BCE cells that had been incubated for 72 h in PDBu were removed from the phorbol ester and replated as described in Materials and Methods, PDBu-treated and control cells replated with similar efficiencies and grew at identical rates (data not shown).
To examine cell specificity, we compared the effect of PDBu on BCE cell proliferation with its effect on that of two other vascular cell types, bovine aortic endothelial cells, and bovine aortic smooth muscle cells. In contrast to its potent inhibition of BCE cells (Fig. 2 A) , PDBu did not affect the proliferation of aortic endothelial cells (Fig. 2 B) even at 1 ILM. The proliferation of aortic smooth muscle cells was also not inhibited by PDBu (Fig. 2 C) , but was, in fact, slightly stimulated.
In shorter term assays for DNA synthesis, PDBu was also effective in inhibiting the response to HDGF. Fig. 3 shows that PDBu inhibited the incorporation of radioactive thymidine by BCE cells in response to increasing concentrations of HDGE Inhibition by even suboptimal (15 nM) PDBu was not overcome by high levels (20 U/ml) of HDGF. Autoradiographic analysis confirmed the inhibition of HDGF action by PDBu. In the absence of factor, cells showed a basal DNA synthetic level corresponding to <20 % labeled nuclei (Fig.  4) . The percent of cells undergoing DNA synthesis was increased over threefold in the presence of HDGF. Addition of PDBu essentially eliminated the HDGF-stimulated DNA synthesis with no apparent effect on the basal level. In the presence or absence of HDGF, cells treated with PDBu displayed a morphological change, extending long processes (not shown).
While phorbol esters have been reported to increase cell growth in synergy with other mitogens, in this case PDBu and HDGF showed antagonistic rather than synergistic actions. This does not seem to be true in all cases of growth stimulation by this class of mitogen. In quiescent BALB/c 3T3 fibroblasts, DNA synthesis was stimulated by both PDBu and HDGF (Table I) . Kaibuchi et al. (1985) recently showed that the stimulation of Swiss 3T3 cell growth by fibroblast growth factor (a growth factor structurally related if not identical to HDGF; Lobb et al., 1986) may involve activation of protein kinase C.
Since the inhibition of growth factor action is not a typical effect of protein kinase C activators, we further investigated the phorbol diester-induced inhibition of BCE cell proliferation for evidence that it was due to protein kinase C activation. We tested five different phorbol derivatives to determine whether there was a correlation between protein kinase C activators and inhibitors of BCE cell response to HDGF (Table  II) . The potent protein kinase C activator 12-O-tetradeca-
HD6Ffumts/m/2 Figure 3 . Effect of phorbol dibutyrate on the concentration-depen- Incorporation of [3H]thymidine by quiescent BALB/c 3T3 cells was determined as described previously (Klagsbrun and Shing, 1985) . The wells contained 0.1% Me2SO and, where indicated, 30 nM PDBu and 4 U per ml HDGF. Each value represents the mean ± SEM for quadruplicate wells.
noylphorbol 13-acetate (TPA) inhibited BCE cell proliferation slightly more than PDBu, with both causing >75 % suppression at 100 nM. ffPhorbol and ¢t-phorbol 12,13-didecanoate, which do not activate protein kinase C (Castagna et al., 1982) , had no significant effect on BCE cell proliferation at 100 nM. At the same concentration, 13-phorbol 12,13-diacerate, a weak protein kinase C activator (Noguchi et al., 1985) , only slightly inhibited BCE cell proliferation. Similar relative potencies were observed for all compounds at 10 nM (data not shown). Another compound tested was ~t-phorbol 12,13-dibutyrate, an inactive stereoisomer of PDBu and therefore perhaps the most suitable control compound. This PDBu isomer had no effect on HDGF-stimulated proliferation or DNA synthesis at concentrations as high as 2 ~tM (data not shown).
We next investigated binding of PDBu to BCE cells using a radioactive ligand-binding assay. BCE cells exhibited specific, saturable binding of PDBu in the same concentration range as that causing inhibition of proliferation (Fig. 5) . Scatchard analysis of these data revealed that PDBu bound at a single class of sites with an apparent Kd of ~8 nM. The maximal binding of PDBu was '~85 fmol/llY cells, or '~5 x 105 receptors per cell.
As noted above, phorbol diesters bind protein kinase C at the same site as the enzyme's presumed endogenous activator, sn-l,2-diacylglycerol (Nishizuka, 1984; Kikkawa et al., 1983 been evaluated as activators of protein kinase C. The most potent of these is DiCs, which activates isolated protein kinase C, displaces PDBu from its receptor, and evokes a number of cellular responses that have been attributed to protein kinase C activation Ebeling et al., 1985; Davis et al., 1985; Lapetina et al., 1985) . Diacylglycerols with shorter chain lengths are much weaker. In par- BCE cell proliferation assays were performed as described in Materials and Methods, with 17 U HDGF per well and 100 nM phorbol compound. The number of attached cells per well when test substances were added was 13,000. Cell numbers are the means + SEM of quadruplicate wells. Previously published in vitro protein kinase C activation data were determined by Noguchi et al. (1985) at 20 nM and Castagna et al. (1982) at 10 ng/ml. * Inhibition = 1 -(number of cell doublings with phorbol compound)/(number of cell doublings in control). Number of cell doublings = log2 (cell number at 72 h)/(initial cell number). Figure 7 . Activation of BCE cytosolic protein kinase C by DiCs or phorbol dibutyrate. Protein kinase activity was assayed as described in Materials and Methods with 50 ~tM [7-32p]ATP (1,350 dpm/pmol), 12 lag protein/ml BCE cytosolic preparation, and, where indicated, 200 lag/ml PS, 2 mM EGTA, 20 ~tg/ml DiC8, and 50 nM PDBu or 13-phorbol. Under these conditions, the rate of protein phosphorylation was constant for at least 60 min (data not shown). Protein phosphorylation is expressed as the amount of 32p incorporated into histone during 50 min/50-ktl aliquot. Each value given is the mean + SEM for quadruplicate aliquots. All values have been corrected for basal protein kinase activity by subtracting the amount of 32p incorporated in the absence of PS, EGTA, DiC8, or phorbol compounds (4,200 + 200 dpm). ticular, DiC4 is two to three orders of magnitude less potent than DiC8 in activation of protein kinase C and in displacing PDBu from its receptor (Ebeling et al., 1985) .
We therefore tested DiC8 and DiC4 for displacement of PDBu from its receptor in BCE cells. We found (Fig. 6) that DiC8 displaced over 90% of the specific binding of PDBu, with 50% displacement occurring at 9 gM DiC8. DiC4, in accordance with its known low affinity for protein kinase C, did not displace PDBu from BCE cells at concentrations as high as 80 I.tM. Attempts to evaluate the effect of DiC8 on BCE cell growth were unsuccessful. DiCa, at concentrations of 100 IxM or less, was rapidly metabolized in the cell cultures (as assessed by the ability of the culture medium to displace [3H]PDBu binding), whereas higher concentrations of DiC8 caused cell rounding and irreversible detachment.
These results are consistent with an interaction of PDBu with protein kinase C in BCE cells. To show that this enzyme exists in the BCE cell and that it is activated by PDBu, we prepared a cytosolic extract from BCE cells as described in Materials and Methods. In preliminary experiments (data not shown), we found that this preparation contained protein kinase activity that required both calcium and PS, i.e., protein kinase C activity. We tested the BCE cytosolic protein kinase C activity to determine whether it was activated by PDBu or diacylglycerol. Other studies have shown that both of these compounds increase the affinity of protein kinase C for calcium, causing it to become more active at suboptimal calcium concentrations (Nishizuka, 1984; Kishimoto et al., 1980) . We assayed a BCE cytosolic preparation under conditions where submaximal protein kinase C activity was observed in the presence of PS and endogenous calcium (Fig.  7) . This protein kinase C activity was increased by ~200% when DiC8 was added. The DiC8-stimulated protein kinase activity required PS and was abolished by EGTA. PDBu stimulated BCE cytosolic protein kinase C in a manner similar to DiC8, while I~-phorbol at the same concentration had no effect. Hydrolysis of radioactive ATP in these reactions, as determined by thin-layer chromatography (Doctrow and Lowenstein, 1985) , was insignificant (<5 %).
As discussed above, many mitogens induce PIP2 hydrolysis in their target cells. It is therefore possible that HDGF might act via such a mechanism in BCE cells. If this were true, then the phorbol ester-induced inhibition observed by us might be a feedback inhibition of phospholipase C, similar to that proposed in other systems (Brock et al., 1985; Rosoff and Cantley, 1985) . To test whether HDGF stimulates PIP2 hydrolysis in BCE cells, we incubated [3H]inositol prelabeled cells with and without HDGF and measured radioactive inositol phosphates as described in Materials and Methods. In the presence or absence of HDGF, we observed no changes in inositol phosphate levels compared with those present before test incubations. For example, in one experiment, the amount of inositol phosphate recovered from the cells was 236,600 + 8,400 cpm/well inositol monophosphate and 12,400 + 600 cpm/well inositol polyphosphates before and after 30 min incubation with HDGF (20 U) or PBS control solutions. Similarly, no changes in inositol phosphates were detected after incubation times of 15 s, 5 min, or 10 min. We also conducted experiments using cells prelabeled with radioactive arachidonic acid to detect diacylglycerol production as previously described (Kaibuchi et al., 1986) . We found no change in diacylglycerol levels in the controls or in the HDGF-treated BCE cells.
Discussion
These results demonstrate that PDBu strongly attenuates the mitogenic response of BCE cells to the basic endothelial mitogen HDGF (Figs. 1, 3 , and 4). We have also observed a similar effect on the response of these cells to retinaderived growth factor (Doctrow, S. R., and J. Sudhalter, unpublished observations), an acidic endothelial mitogen which, like HDGF and related factors, is angiogenic in vivo (DAmore, 1982) . These were unexpected findings, since PDBu and other protein kinase C activators are mitogenic or co-mitogenic for many other cell types (Dicker and Rozengurt, 1980; Kaibuchi et al., 1985; Gelfand et al., 1985; Bachrach et al., 1985; Balk et al., 1984) including the bovine aortic smooth muscle cells (Fig. 2 C) and BALB/c 3T3 fibroblasts (Table I ) that we tested. (This is not, however, the first example of a cell whose growth is inhibited by phorbol diesters. These compounds inhibit the proliferation of HL-60 promyeloid leukemia cells, concomitantly causing them to differentiate into cells with the properties of normal macrophages [Huberman and Callahan, 1979; Ebeling et al., 1985] .)
In contrast to its potent inhibition of BCE cell growth, PDBu had no effect on the proliferation of bovine aortic endothelial cells (Fig. 2 B) . This lack of effect is not likely to be due to a protein kinase C deficiency in the aortic cells, since phorbol diesters at nanomolar concentrations induce a morphological change in bovine aortic endothelial cells and cause them to produce plasminogen activator (Gross et al., 1982) . In addition, Mackie et al. (1986) have measured protein kinase C in extracts from bovine aortic endothelial and bovine pulminary arterial endothelial cells and report a specific activity (0.27 + 0.02 nmol/mg protein per min) in agreement with that measured by us in BCE preparations (~0.2 nmol/mg protein per min). While the reason for the difference that we observe between BCE cells and bovine aortic endothelial cells is not clear, it may indicate some specificity of PDBu-mediated growth inhibition for small vessel endothelium.
A number of our observations suggest that PDBu interacts with BCE cells through protein kinase C. Inhibition of BCE cell growth occurred at PDBu concentrations well within the range of those shown to increase protein kinase C in other systems (Rozengurt et al., 1983; Kikkawa et al., 1983) . Various phorbol compounds inhibited HDGF-mediated growth with an order of potency that correlated very closely with their known relative potencies as activators of isolated protein kinase C (Table II) .
Our binding studies (Fig. 5) revealed that PDBu interacts with a specific, saturable receptor on BCE cells. The apparent dissociation constant for this interaction (8 nM) agrees with the Ks0 for the inhibition of BCE cell growth (6 + 4 nM). It is therefore likely that the receptor detected in our binding studies mediates the growth effect. The PDBu receptor in BCE cells has affinity for the protein kinase C-activating diacylglycerol DiCs, but not for the inactive DiC4 (Fig.  6) . The concentration range of DiC8 required to compete with PDBu for binding to BCE cells is equivalent to that needed to displace PDBu from A431 cells (Davis et al., 1985) and HL-60 cells (Ebeling et al., 1985) , two cell types in which PDBu is thought to exert its effects via protein kinase C. In addition, similar concentrations of DiC8 have been shown to activate protein kinase C in intact platelets (Lapetina et al., 1985) . Because an sn-l,2-diacylglycerol is the postulated endogenous activator of protein kinase C (Nishizuka, 1984) , the affinity of the PDBu receptor in BCE cells for DiC8 is perhaps the most important piece of evidence that this receptor is indeed protein kinase C. This interpretation is strengthened by the observation that DiCa, a very weak protein kinase C activator (Ebeling et al., 1985; Lapetina et al., 1985) , did not displace PDBu binding even though both DiC4 and PDBu are dibutyryl esters.
This study also demonstrates that protein kinase C can be detected enzymatically in a BCE cytosolic preparation and that the enzyme is activated by PDBu (Fig. 7) . This was not unexpected since protein kinase C has been found in many different tissues. However, our data eliminate the remote possibility that BCE cells are either lacking in protein kinase C or contain a similar enzyme that is unresponsive to diacylglycerols or phorbol diesters.
We were unable to detect HDGF-induced changes in inositol phosphate or diacylglycerol levels in BCE cells. We conclude that HDGE while stimulating BCE cell growth, does not seem to cause PIP2 hydrolysis under our conditions. Although we used techniques that have successfully demonstrated mitogen-induced PIP2 hydrolysis in other systems, we cannot exclude the possibility that a functionally important, but minor, pool of messenger is being masked in our experiments. But, presently, we have no evidence that HDGF activates protein kinase C in these cells, which is consistent with our observation that HDGF and phorbol diesters do not have a synergistic or additive effect in our experiments.
The molecular mechanisms of BCE cell growth stimulation by HDGF and its inhibition by protein kinase C remain unknown. Our data indicate a protein kinase C-mediated uncoupling of HDGF from its intracellular effects, essentially desensitizing the endothelial cells to mitogens. This desensitization might involve down-regulation of HDGF receptors or disruption of one or more of the intracellular events required to transduce the mitogenic signal to the nucleus. It is not likely that PDBu competes directly with a single step in the normal signal transduction cascade of HDGF, because very high amounts of growth factor do not overcome inhibition by even subsaturating concentrations of PDBu (Fig. 3) . PDBu-induced down-regulation of protein kinase C, a phenomenon reported in certain other cells (Kaibuchi et al., 1986) , does not explain our results, since PDBu pretreatment completely inhibits DNA synthesis in BCE cells without affecting their [3H]PDBu binding capacity (data not shown).
A process that can render capillary endothelial cells insensitive to mitogens is likely to be crucial to the formation of functional capillaries. Angiogenesis in vivo requires not only endothelial cell proliferation, but also organization of these cells into nonproliferating tubes (Folkman et al., 1982) . When capillary endothelial cells are induced to form tubes in culture, they have a greatly reduced rate of mitosis compared with cells that are not organizing in this fashion (Folkman and Haudenschild, 1980; Madri, et al., 1983) . In vivo, growing capillary networks consist of proliferating endothelial cells that are often in close proximity to nonproliferating, tube-forming cells (Ausprunk and Folkman, 1977) . Thus, mechanisms must exist for locally suppressing the growth of certain endothelial cells even in the presence of significant amounts of mitogen. It is possible that protein kinase C activation is an intracellular signal inducing endothelial cells to become desensitized to angiogenic endothelial mitogens and perhaps, as discussed below, to organize into tubes. Inasmuch as tube formation is considered a more differentiated state than proliferation for endothelial cells (Madri et al., 1983) , protein kinase C activation in response to specific localized signals (e.g., extraceUular matrix composition) may promote differentiation in these cells.
Previously reported effects of TPA on capillary endothelial cells support a phorbol diester-induced differentiation. When a capillary endothelial cell monolayer on the surface of a collagen gel is treated with TPA, the cells organize into capillary-like tubes inside the gel (Montesano and Orci, 1985) . TPA causes capillary endothelial cell monolayers to produce proteases, which may allow them to modify their substratum and invade tissues during certain phases of angiogenesis (Gross et al., 1982) . The TPA-induced effects leading to tube formation and protease production occur independently of cell growth, and therefore are consistent with our present observation that protein kinase C activation suppresses the proliferation of these cells in response to mitogens. Most recently, Lombardi et al. (1986) have demonstrated that TPA induces cultured BCE cells to exhibit diaphragmed fenestrae, a differentiated characteristic that was previously difficult to demonstrate in vitro.
These previous reports, together with our present findings, suggest that protein kinase C activation may be one intracellular signal for switching capillary endothelial cells from a proliferative into a more differentiated state. The precise role played by protein kinase C in angiogenesis is not easily predicted by in vitro experiments. It is highly unlikely that indiscriminate activation of this kinase in a population of endothelial cells would be sufficient to trigger the construction of a complete vascular system in vivo, especially since it would inhibit their proliferation. However, selective modula-tion of this enzyme during appropriate stages of angiogenesis might help to direct this complex process. We speculate that protein kinase C-induced uncoupling of mitogen action is one important step promoting endothelial cell organization into mature, nongrowing capillaries.
